6-36855935-T-C
Variant summary
Our verdict is Uncertain significance. The variant received 5 ACMG points: 6P and 1B. PM1PM2PP2PP5BP4
The NM_016059.5(PPIL1):c.379A>G(p.Thr127Ala) variant causes a missense change. The variant allele was found at a frequency of 0.0000514 in 1,614,078 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Consequence
NM_016059.5 missense
Scores
Clinical Significance
Conservation
Publications
- pontocerebellar hypoplasia, type 14Inheritance: AR Classification: STRONG, MODERATE Submitted by: Labcorp Genetics (formerly Invitae), Broad Center for Mendelian Genomics, Ambry Genetics
Genome browser will be placed here
ACMG classification
Our verdict: Uncertain_significance. The variant received 5 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
PPIL1 | NM_016059.5 | c.379A>G | p.Thr127Ala | missense_variant | Exon 4 of 4 | ENST00000373699.6 | NP_057143.1 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0000197 AC: 3AN: 152068Hom.: 0 Cov.: 32 show subpopulations
GnomAD2 exomes AF: 0.0000835 AC: 21AN: 251416 AF XY: 0.0000662 show subpopulations
GnomAD4 exome AF: 0.0000547 AC: 80AN: 1461892Hom.: 0 Cov.: 32 AF XY: 0.0000619 AC XY: 45AN XY: 727246 show subpopulations
GnomAD4 genome AF: 0.0000197 AC: 3AN: 152186Hom.: 0 Cov.: 32 AF XY: 0.0000403 AC XY: 3AN XY: 74390 show subpopulations
ClinVar
Submissions by phenotype
Pontocerebellar hypoplasia, type 14 Pathogenic:2
- -
Low frequency in gnomAD population databases (PM2_sup). Variant is located in a mutational hotspot (PM1_mod). Detected in trans with a pathogenic variant in an affected case (PM3_s). -
Congenital pontocerebellar hypoplasia Pathogenic:1
- -
not provided Pathogenic:1
Published functional studies demonstrate a damaging effect of decreased protein level (PMID: 33220177); In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; This variant is associated with the following publications: (PMID: 33220177) -
not specified Uncertain:1
Variant classified as Uncertain Significance - Favor Pathogenic. The p.Thr127Ala variant was identified with a canonical splice variant (phase not determined) in another family with two relatives with a neurodevelopmental phenotype consisting of profound global developmental delays, abnormal muscle tone, and intractable seizures (Gleeson et al, unpublished data). It was also identified in this family in a compound heterozygous state with a loss of function variant in two siblings with profound global developmental delays, microcephaly, intractable seizures, hypotonia, hypoplasia of the corpus callosum, and cortical vision impairment by the Broad Institute Rare Genomes Project. In vitro functional studies of p.Thr127Ala demonstrate a reduction of protein levels in cultured cells (Joseph Gleeson laboratory, UC San Diego, unpublished data) although this observation may not represent disrupted biological function. This variant has been identified in 0.014% of non-Finnish European chromosomes by the Genome Aggregation Database (gnomAD, http://gnomad.broadinstitute.org). Computational prediction tools and amino acid conservation analysis suggest that the p.Thr127Ala variant may impact the protein, though this information is not predictive enough to determine pathogenicity through a protein sequence change. Currently, there is moderate evidence to support an association between PPIL1 and a severe neurodevelopmental phenotype. In summary, while there is suspicion for a pathogenic role, the clinical significance of the p.Thr127Ala variant remains uncertain. ACMG/AMP Criteria applied: PS3_Moderate, PM2_Supporting, PP3. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at